Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell ImpactOSTO:CI +0.74% EV-to-EBIT is -0.36 as of Aug. 11, 2026. The stock has 7 warning signs investors should review. Among 2,380 Industrial Products companies, Cell Impact ranks worse than 42016.76% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cell Impact's Enterprise Value for the quarter that ended in Mar. 2026 was kr67.92 Mil.
Cell Impact's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-123.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact EV-to-EBIT Related Terms
Cell Impact EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Cell Impact's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Metal Fabrication subindustry, Cell Impact's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Impact EV-to-EBIT vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Cell Impact's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cell Impact's EV-to-EBIT falls into.
Cell Impact's current Enterprise Value is kr44.33 Mil.
Cell Impact's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-123.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact (OSTO:CI) has a EV-to-EBIT of -0.36 as of Aug. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #999999 out of 2380 companies in the Industrial Products industry.
Is Cell Impact's EV-to-EBIT too high?
Cell Impact's current EV-to-EBIT is -0.36. Based on the distribution chart, Cell Impact ranks #999999 out of 2380 companies in the Industrial Products industry, which is in the bottom quartile relative to peers.
How does Cell Impact's EV-to-EBIT compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #999999 out of 2380 companies for EV-to-EBIT. This places Cell Impact in the lower half of its industry. The industry median EV-to-EBIT is 20.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Industrial Products company?
The median EV-to-EBIT among Industrial Products companies is 20.22, based on 2,380 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median EV-to-EBIT is 20.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current EV-to-EBIT is -0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Fairly Valued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.05 — trading 8.8% above its estimated fair value. The current EV-to-EBIT is -0.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current EV-to-EBIT is -0.36 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:CI has been successfully added to your 
